Invesco Ltd. Sera Prognostics, Inc. Transaction History

Invesco Ltd.

$503 Billion
Q1 2025

A detailed history of Invesco Ltd. transactions in Sera Prognostics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 13,124 shares of SERA stock, worth $26,641. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,124

Previous 13,708 4.26%

Holding current value

$26,641

Previous $118,000 59.32%

% of portfolio

0.0%

Previous 0.0%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$3.54 - $8.33 $2,067 - $4,864	-584 Reduced 4.26%	13,124 $48,000
Q4 2024 Feb 13, 2025	SELL	$6.03 - $8.83 $3.49 Million - $5.11 Million	-578,489 Reduced 97.69%	13,708 $118,000
Q3 2024 Nov 12, 2024	BUY	$5.29 - $8.43 $3.06 Million - $4.88 Million	578,877 Added 4345.92%	592,197 $4.62 Million
Q2 2024 Aug 13, 2024	SELL	$5.6 - $11.69 $3.41 Million - $7.11 Million	-608,514 Reduced 97.86%	13,320 $78,000
Q1 2024 May 14, 2024	BUY	$5.05 - $10.0 $3.14 Million - $6.22 Million	621,834 New	621,834 $5.66 Million

Others Institutions Holding SERA

# of Institutions

Shares Held

22.6M

Call Options Held

300

Put Options Held

800

View Full List

About SERA PROGNOSTICS, INC.

Ticker SERA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 29,596,900
Market Cap $60.1M
Description
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...

More about SERA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account